相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concentrations of medetomidine enantiomers and vatinoxan, an α2-adrenoceptor antagonist, in plasma and central nervous tissue after intravenous coadministration in dogs
Juhana M. Honkavaara et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2020)
Investigation of the effects of vatinoxan on somatic and visceral antinociceptive efficacy of medetomidine in dogs
Vilhelmiina Huuskonen et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2020)
Peripherally acting α-adrenoceptor antagonist MK-467 with intramuscular medetomidine and butorphanol in dogs: A prospective, randomised, clinical trial
I. J. Kallio-Kujala et al.
VETERINARY JOURNAL (2018)
Effects of constant rate infusions of dexmedetomidine or MK-467 on the minimum alveolar concentration of sevoflurane in dogs
Rachel C. Hector et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2017)
Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2-antagonist MK-467 in dogs
Flavia Restitutti et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2017)
Effects of MK-467 on the antinociceptive and sedative actions and pharmacokinetics of medetomidine in dogs
R. C. Bennett et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2016)
The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia
Peter J. Pascoe
VETERINARY ANAESTHESIA AND ANALGESIA (2015)
Effects of Lidocaine, Dexmedetomidine or Their Combination on the Minimum Alveolar Concentration of Sevoflurane in Dogs
Rafael Moran-Munoz et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2014)
Cardiovascular, respiratory, electrolyte and acid-base balance during continuous dexmedetomidine infusion in anesthetized dogs
Jonathan M. Congdon et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2013)
Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine
Mari H. Vainionpaa et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2013)
Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs
Nicole G. Rolfe et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2012)
Cardiovascular Effects of Dexmedetomidine Sedation in Children
Jackson Wong et al.
ANESTHESIA AND ANALGESIA (2012)
Admission base excess as a predictor of transfusion requirement and mortality in dogs with blunt trauma: 52 cases (2007-2009)
Jenefer R. Stillion et al.
JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE (2012)
Influence of MK-467, a Peripherally Acting α2-Adrenoceptor Antagonist on the Disposition of Intravenous Dexmedetomidine in Dogs
Juhana Honkavaara et al.
DRUG METABOLISM AND DISPOSITION (2012)
The effects of increasing doses of MK-467, a peripheral alpha2-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs
J. M. Honkavaara et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2011)
Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects
Amir Snapir et al.
ANESTHESIOLOGY (2006)
Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs
PJ Pascoe et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2006)
Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog
JC Murrell et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2005)
Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs
A Valverde et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2004)
The effects of increasing plasma concentrations of dexmedetomidine in humans
TJ Ebert et al.
ANESTHESIOLOGY (2000)
分享论文
